MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹88 Cr | ₹78 Cr | ₹85 Cr | ₹83 Cr | ₹73 Cr |
What is the latest Total Current Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹88 Cr |
| Mar2025 | ₹78 Cr |
| Mar2024 | ₹85 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹73 Cr |
How is Total Current Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹88 Cr | 12.48 | |
| Mar2025 | ₹78 Cr | -7.56 | |
| Mar2024 | ₹85 Cr | 2.40 | |
| Mar2023 | ₹83 Cr | 13.60 | |
| Mar2022 | ₹73 Cr | - | |
Compare Total Current Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹375.0 Cr | -2.5% | -17.9% | -20.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -2.5% |
-17.9% |
-20.1% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses